These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 16912967)

  • 21. Voriconazole, but not terbinafine, markedly reduces alfentanil clearance and prolongs its half-life.
    Saari TI; Laine K; Leino K; Valtonen M; Neuvonen PJ; Olkkola KT
    Clin Pharmacol Ther; 2006 Nov; 80(5):502-8. PubMed ID: 17112806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose-dependent pharmacokinetics of a new Na+/H+ exchanger inhibitor KR-33028 in rats.
    Kim YH; Yoo SD; Kim YS; Lee KH; Lee HS
    Biopharm Drug Dispos; 2007 Nov; 28(8):423-9. PubMed ID: 17828714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB; Dowell JA; Pratt RD
    Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phase I and pharmacokinetic study of lapatinib in combination with letrozole in patients with advanced cancer.
    Chu QS; Cianfrocca ME; Goldstein LJ; Gale M; Murray N; Loftiss J; Arya N; Koch KM; Pandite L; Fleming RA; Paul E; Rowinsky EK
    Clin Cancer Res; 2008 Jul; 14(14):4484-90. PubMed ID: 18628463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of diclofenac and its interaction with enrofloxacin in sheep.
    Rahal A; Kumar A; Ahmad AH; Malik JK
    Res Vet Sci; 2008 Jun; 84(3):452-6. PubMed ID: 17692878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absolute bioavailability of sitagliptin, an oral dipeptidyl peptidase-4 inhibitor, in healthy volunteers.
    Bergman A; Ebel D; Liu F; Stone J; Wang A; Zeng W; Chen L; Dilzer S; Lasseter K; Herman G; Wagner J; Krishna R
    Biopharm Drug Dispos; 2007 Sep; 28(6):315-22. PubMed ID: 17575559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Understanding the BIG results: Insights from the BIG 1-98 trial analyses.
    Wardley AM
    Adv Ther; 2008 Dec; 25(12):1257-75. PubMed ID: 19096768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced methadone clearance during aromatase inhibition.
    Lu WJ; Thong N; Flockhart DA
    J Clin Psychopharmacol; 2012 Aug; 32(4):511-7. PubMed ID: 22722506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel tocolytic agent: effects of letrozole on gestational length and parturition time.
    Kafali H; Iriadam M
    Am J Perinatol; 2007 May; 24(5):323-6. PubMed ID: 17516308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term administration of estrogen or tamoxifen to ovariectomized rats affords neuroprotection to hippocampal neurons by modulating the expression of Bcl-2 and Bax.
    Sharma K; Mehra RD
    Brain Res; 2008 Apr; 1204():1-15. PubMed ID: 18342840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of age and single versus multiple dose pharmacokinetics of letrozole (Femara) in breast cancer patients.
    Pfister CU; Martoni A; Zamagni C; Lelli G; De Braud F; Souppart C; Duval M; Hornberger U
    Biopharm Drug Dispos; 2001 Jul; 22(5):191-7. PubMed ID: 11745921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of mammary gland carcinogenesis by post-initiation treatment of rats with tamoxifen or indole-3-carbinol or their combination.
    Malejka-Giganti D; Parkin DR; Bennett KK; Lu Y; Decker RW; Niehans GA; Bliss RL
    Eur J Cancer Prev; 2007 Apr; 16(2):130-41. PubMed ID: 17297389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and bioavailability of a newly synthesized dihydropyridine compound with multidrug resistance reversal activity.
    Zhou XF; Macdiarmid J; Coburn RA; Morris ME
    Biopharm Drug Dispos; 2005 Oct; 26(7):279-85. PubMed ID: 15991253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Late extended adjuvant treatment with letrozole improves outcome in women with early-stage breast cancer who complete 5 years of tamoxifen.
    Goss PE; Ingle JN; Pater JL; Martino S; Robert NJ; Muss HB; Piccart MJ; Castiglione M; Shepherd LE; Pritchard KI; Livingston RB; Davidson NE; Norton L; Perez EA; Abrams JS; Cameron DA; Palmer MJ; Tu D
    J Clin Oncol; 2008 Apr; 26(12):1948-55. PubMed ID: 18332475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Letrozole suppresses plasma estradiol and estrone sulphate more completely than anastrozole in postmenopausal women with breast cancer.
    Dixon JM; Renshaw L; Young O; Murray J; Macaskill EJ; McHugh M; Folkerd E; Cameron DA; A'Hern RP; Dowsett M
    J Clin Oncol; 2008 Apr; 26(10):1671-6. PubMed ID: 18375896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen.
    Chen J; Power KA; Mann J; Cheng A; Thompson LU
    Exp Biol Med (Maywood); 2007 Sep; 232(8):1071-80. PubMed ID: 17720953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma protein binding of letrozole, a new nonsteroidal aromatase enzyme inhibitor.
    Colussi DM; Parisot CY; Lefèvre GY
    J Clin Pharmacol; 1998 Aug; 38(8):727-35. PubMed ID: 9725549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-implantation effect of droloxifene in rats and its relationship with anti-estrogenic activity.
    Huang Y; Shen Y; Feng Y; Cao L; Leng Y
    Acta Pharmacol Sin; 2005 Oct; 26(10):1243-7. PubMed ID: 16174441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of letrozole extended adjuvant therapy according to estrogen receptor and progesterone receptor status of the primary tumor: National Cancer Institute of Canada Clinical Trials Group MA.17.
    Goss PE; Ingle JN; Martino S; Robert NJ; Muss HB; Piccart MJ; Castiglione M; Tu D; Shepherd LE; Pritchard KI; Livingston RB; Davidson NE; Norton L; Perez EA; Abrams JS; Cameron DA; Palmer MJ; Pater JL;
    J Clin Oncol; 2007 May; 25(15):2006-11. PubMed ID: 17452676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of high doses of cyanocobalamin administered by intravenous injection for 26 weeks in rats.
    Nava-Ocampo AA; Pastrak A; Cruz T; Koren G
    Clin Exp Pharmacol Physiol; 2005; 32(1-2):13-8. PubMed ID: 15730428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.